首页> 美国卫生研究院文献>World Journal of Gastroenterology >Cocultivation of umbilical cord blood CD34+ cells with retro-transduced hMSCs leads to effective amplification of long-term culture-initiating cells
【2h】

Cocultivation of umbilical cord blood CD34+ cells with retro-transduced hMSCs leads to effective amplification of long-term culture-initiating cells

机译:脐血CD34 +细胞与逆转hMSCs共同培养可有效扩增长期培养起始细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To establish a novel coculture system for ex vivo expansion of umbilical cord blood(UCB) hematopoietic progenitors using thrombopoietin (TPO)/Flt-3 ligand (FL)-transduced human marrow-derived mesenchymal stem cells (tfhMSCs) as feeder.METHODS: UCB CD34+ cells were isolated and cultured using four culture systems in serum-containing or serum-free medium. Suitable aliquots of cultured cells were used to monitor cell production, clonogenic activity, and long-term culture-initiating culture (LTC-IC) output. Finally, the severe-combined immunodeficient (SCID) mouse-repopulating cell (SRC) assay was performed to confirm ability of the cultured cells to reconstitute long-term hematopoiesis.RESULTS: There were no significant differences in the number of total nucleated cells among different culture systems in serum-containing medium during 21-d culture. However, on d 14, the outputs of CD34+ cells, CFU-C and CFU-GEMM in tfhMSCs coculture system were significantly enhanced. LTC-IC assay demonstrated that the tfhMSCs coculture system had the most powerful activity. The severe-combined immunodeficient (SCID) mouse repopulating cell (SRC) assay confirmed extensive ability of the expanded cells to reconstitute long-term hematopoiesis. Furthermore, PCR analysis demonstrated the presence of human hematopoietic cells in the bone marrow and peripheral blood cells of NOD/SCID mice.CONCLUSION: The TPO/FL-transduced hMSCs, in combination with additive cytokines, can effectively expand hematopoietic progenitors from UCB in vitro and the tfhMSCs coculture system may be a suitable system for ex vivo manipulation of primitive progenitor cells under contact culture conditions.
机译:目的:建立新的共培养系统,以血小板生成素(TPO)/ Flt-3配体(FL)转导的人骨髓间充质干细胞(tfhMSCs)为饲养细胞,体外扩增脐带血(UCB)造血祖细胞。 :分离UCB CD34 + 细胞,并使用四种培养系统在含血清或无血清的培养基中培养。培养细胞的合适等分试样用于监测细胞产量,克隆形成活性和长期培养起始培养物(LTC-IC)输出。最后,进行了严重结合免疫缺陷(SCID)小鼠增殖细胞(SRC)分析,以确认培养的细胞重建长期造血的能力。结果:不同细胞之间的总有核细胞数量没有显着差异培养系统在含血清的培养基中培养21天。然而,在第14天,tfhMSCs共培养系统中CD34 + 细胞,CFU-C和CFU-GEMM的输出显着增加。 LTC-IC分析表明,tfhMSCs共培养系统具有最强大的活性。严重联合免疫缺陷(SCID)小鼠再生细胞(SRC)分析证实了扩增后的细胞重建长期造血的广泛能力。此外,PCR分析表明,NOD / SCID小鼠的骨髓和外周血细胞中存在人类造血细胞。结论:TPO / FL转导的hMSC与加性细胞因子结合可以有效地扩增UCB的造血祖细胞并且tfhMSCs共培养系统可以是在接触培养条件下离体操纵原始祖细胞的合适系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号